Stock listing

Euronext:ALTHX THX Pharma Action

Home listing (Euronext) of THX Pharma

Follow THX Pharma into a list and get an email when it puts out news.

Share price · EURONEXT:ALTHX

€2.97 EUR -0.24 (-7.5%)

Close on Nov 20, 2026

Past year +77.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€2.96 – €3.21 EURNov 20, 2026
Volume
85,934 sharesNov 20, 2026
Market cap
€43.03M EURAt the close on Nov 20, 2026 · price × 14.49M shares outstanding
52-week range
€1.49 – €5.10 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€220,397 EURMedian day 46,650 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
THX Pharma logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALTHX · Home€2.97 EUR-0.24 (-7.5%)85,934€3.21€3.21€2.955€3.21Close on Nov 20, 2026
Frankfurt:3VG€3.11 EUR+0.03 (+1.0%)—€3.11€3.11€3.11€3.08Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALTHX · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.97-0.24-7.5%€3.21€3.21€2.95585,934
€3.21+0.035+1.1%€3.19€3.32€3.1929,469
€3.175-0.095-2.9%€3.25€3.26€3.1528,577
€3.27-0.05-1.5%€3.32€3.325€3.1947,821
€3.32-0.16-4.6%€3.48€3.48€3.27550,135
€3.48-0.02-0.6%€3.50€3.56€3.34541,651
€3.50+0.08+2.3%€3.40€3.58€3.3663,677
€3.42+0.09+2.7%€3.35€3.45€3.30541,196
€3.33+0.13+4.1%€3.21€3.33€3.2125,639
€3.20-0.06-1.8%€3.22€3.25€3.04573,280
€3.26-0.18-5.2%€3.40€3.40€3.19568,810
€3.44+0.04+1.2%€3.38€3.45€3.2882,550
€3.40+0.075+2.3%€3.28€3.40€3.20535,799
€3.325+0.015+0.5%€3.25€3.325€3.20530,662
€3.31-0.17-4.9%€3.48€3.48€3.2873,733
€3.48+0.02+0.6%€3.495€3.495€3.38545,435
€3.46+0.13+3.9%€3.35€3.51€3.31559,648
€3.33+0.06+1.8%€3.25€3.33€3.2332,365
€3.27+0.11+3.5%€3.16€3.285€3.1616,943
€3.16-0.04-1.3%€3.24€3.27€3.1642,670
€3.20-0.13-3.9%€3.33€3.36€3.1839,217
€3.33+0.05+1.5%€3.32€3.395€3.27533,211
€3.28+0.07+2.2%€3.21€3.28€3.10529,586
€3.21+0.08+2.6%€3.15€3.21€3.0921,014
€3.13-0.08-2.5%€3.21€3.28€3.1242,044
€3.21+0.21+7.0%€2.96€3.25€2.9557,080
€3.00-0.035-1.2%€3.015€3.09€2.9934,546
€3.035-0.055-1.8%€3.11€3.135€3.03510,534
€3.09+0.015+0.5%€3.09€3.13€3.0515,694
€3.075+0.095+3.2%€3.00€3.075€2.9935,840
€2.98-0.27-8.3%€3.25€3.25€2.9780,252
€3.25-0.02-0.6%€3.245€3.325€3.24534,978
€3.27+0.13+4.1%€3.14€3.30€3.1442,490
€3.14-0.02-0.6%€3.14€3.14€2.9282,687
€3.16-0.24-7.1%€3.32€3.32€3.06146,959
€3.40-0.01-0.3%€3.37€3.45€3.29572,237
€3.41-0.115-3.3%€3.57€3.57€3.295110,295
€3.525+0.14+4.1%€3.42€3.60€3.4297,780
€3.385-0.015-0.4%€3.385€3.455€3.3841,394
€3.40-0.02-0.6%€3.39€3.455€3.3556,189
€3.42+0.06+1.8%€3.38€3.57€3.3591,187
€3.36+0.02+0.6%€3.36€3.41€3.3437,045
€3.34-0.01-0.3%€3.35€3.35€3.2739,472
€3.35-0.08-2.3%€3.41€3.425€3.34545,479
€3.43+0.13+3.9%€3.32€3.465€3.30552,980
€3.30+0.04+1.2%€3.25€3.34€3.2548,260
€3.26+0.02+0.6%€3.25€3.34€3.2357,471
€3.24-0.10-3.0%€3.36€3.36€3.2062,842
€3.34+0.015+0.5%€3.36€3.43€3.3155,069
€3.325-0.055-1.6%€3.40€3.44€3.3094,317
€3.38-0.10-2.9%€3.465€3.545€3.3875,547
€3.48-0.29-7.7%€3.89€3.92€3.42392,499
€3.77-0.06-1.6%€3.84€3.86€3.7633,248
€3.83+0.04+1.1%€3.80€3.865€3.7277,495
€3.79-0.05-1.3%€3.88€3.88€3.72574,215
€3.84-0.29-7.0%€4.08€4.10€3.83211,065
€4.13+0.03+0.7%€4.39€4.39€4.005196,552
€4.10-0.035-0.8%€4.21€4.21€4.00538,377
€4.135-0.09-2.1%€4.24€4.24€4.1243,882
€4.225+0.095+2.3%€4.15€4.335€4.1572,403
€4.13-0.10-2.4%€4.22€4.25€4.1138,196
€4.23+0.055+1.3%€4.16€4.36€4.11100,631
€4.175+0.085+2.1%€4.135€4.19€4.13515,258
€4.09-0.145-3.4%€4.235€4.235€4.0937,186
€4.235-0.045-1.1%€4.275€4.32€4.1443,558
€4.28-0.13-2.9%€4.425€4.47€4.1662,468

Splits

1 split · EURONEXT:ALTHX · every price before a split is adjusted for it

DayRatioWhat
26-for-25Split
Ticker
Euronext:ALTHX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

All THX Pharma news

Financings

  • Rights offering of new shares with shareholders' preferential subscription rights

    Nov 13, 2025 · US$9.13M

    Closed: €7.84M raised · €1.8 a share · Portzamparc BNP Paribas

    Dealers: Portzamparc BNP Paribas (lead)

    Buyers: Funds managed by Odyssée Venture (3 500 000 € commitment); Market Wizards B.V. (194,443 shares for €349,997.40 as guarantor); TreeCap B.V. (175,000 shares for €315,000.00 as guarantor); Gestys (155,555 shares for €279,999.00 as guarantor); Friedland Gestion (136,110 New Shares for €244,998.00 as guarantor); Maitice Gestion (97,221 New Shares for €174,997.80 as guarantor); Multi stratégies SA - SICAV RAIF (58,333 New Shares for €104,999.40 as guarantor); Auriga Partners (55,555 New Shares for €99,999.00 as guarantor); Allia-Tech Asset Management (46,349 New Shares for €83,428.20 as guarantor); Montpensier-Arbevel (guarantee commitment of €50,000); Samuel Fisher (subscription commitment of €50,000); Mathieu Charvériat (10 000 € commitment); Fonds gérés par Odyssée Venture (1,699,531 shares for €3,059,155.80 as guarantor); Samuel Fischer (27,777 New Shares for €49,998.60 as guarantor)

    Insiders: CEO Mathieu Charvériat and CFO Christine Placet each committed 10 000 €

    Use of proceeds: To develop and commercialize its two assets, Batten-1 and TX01, and its antisense oligonucleotide platform

    Announced Oct 23, 2025 · Closed Nov 13, 2025

Read by 6ix AI from the company's releases

Decks

THX Pharma on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 28 in all · newest Nov 10, 2026 · oldest 2025
Decks
21 decks · latest Apr 5, 2024

Where THX Pharma is listed

ListingExchangeCountryCurrency
Euronext:ALTHX · Home listing · This pageEuronextFranceEUR
gettex:3VGgettexGermanyEUR
LS Exchange:A2H6LXLS ExchangeGermanyEUR
Lang & Schwarz:A2H6LXLang & SchwarzGermanyEUR
Frankfurt:3VGFrankfurtGermanyEUR
Munich:3VGMunichGermanyEUR
Turquoise:ALTHXPTurquoiseUnited KingdomEUR
Stuttgart:3VGStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about THX Pharma.